Navigation Links
European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew
Date:9/3/2009

reby providing an improved environment for wound closure. Acticoat(TM) dressings are now sold by Smith Nephew in over 30 countries and are used extensively for serious wounds and traumatic injury.

About Smith Nephew

Smith Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.

About NUCRYST Pharmaceuticals

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops manufactures and commercializes and using SILCRYST(TM), its patented atomically disordered nanocrystalline silver technology. NUCRYST licensed world-wide rights for SILCRYST(TM) wound care coating products to Smith Nephew plc, which markets these products in over 30 countries under their Acticoat(TM) trademark. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by pain, infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form, referred to as NPI 32101, for use in medical devices and as an active pharmaceutical ingredient.

Acticoat(TM) is a trademark of Smith Nephew plc

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp.

This
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. Launch of second European Cancer Research Funding survey
7. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
8. Pharsight to Host European Software Conference
9. OmniGuide Begins European Commercialization
10. Paving the way for future pan-European clinical trials
11. US, European cancer educators gather in Alabama for meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...ion at the 21st Annual Piper Jaffray Health Care C...tern Time will be webcast live at www.celltherape...ce in Holmes 1 at the New York Palace Hotel, and w...ation. , , Piper Jaffray Hea...
(Date:12/1/2009)...nnual mammography screening may increase breast ca...position to breast cancer, according to a study pr...gical Society of North America (RSNA). , "For w...very important, but a careful approach should be t...ung women, particularly under age 30," said Marijk...
(Date:12/1/2009)... with elastography can help differentiate between ... a study presented today at the annual meeting of ..., "High-frequency ultrasound with elastography h... cancer diagnosis," said lead author Eliot L. Sieg...logy at the University of Maryland School of Medic...
(Date:12/1/2009)...controlled clinical trial presented today at the a... America (RSNA) reveal that one in five patients w...blood to the legs and other parts of the body also...se. , Peripheral arterial disease (PAD) occurs ... other substances, builds up in the arteries, limi...
(Date:12/1/2009)...dolescent obesity is a major public health problem...ulting in 4-5 million overweight youth in the Unit...09 issue of the Journal of the American Dietetic ... weight control behaviors, including dietary intak...escents who lost weight and those who did not in o...
Breaking Medicine News(10 mins):Health News:Mammography may increase breast cancer risk in some high-risk women 2Health News:Special ultrasound accurately identifies skin cancer 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:Investigators identify successful weight control strategies for adolescents 2
... a biomarker that may be useful for predicting the...common cancer in young children. The research, pub... journal Cancer Cell , also provides new informat... of Vitamin A that has important influences over t...
...ation to receive accreditation , , GREEN BAY, Wis... of the first four hospitals in the country to be ...or Breast Centers (NAPBC), administered by the Ame...0303/CG78204LOGO-b ) , , "This is an outstanding ...
... are using Orion Health,s Concerto Whiteboard to i...rkflow for more efficient management in emergency ...t from the 2009 Annual HIMSS Conference & Exhi... Orion Health, Inc. , a market leader in providing...
...e Lehigh Valley Lends Support , , HARRI...y Everette James today kicked off National Public ...ound the Capitol complex to bring awareness to the...ize that we cannot just talk about the health of P...
...prevalent chronic cardiac condition. Around 30 mil...ncidence is still increasing: more cases are being... and more are surviving a heart attack but with da...te heart failure admissions were "overwhelming" ho...
...a today announced the formation of its Scientific ... to assist the company in the design and execution...cardiopulmonary medicine and Nitric Oxide (NO) and...actice of Medicine at Harvard Medical School , an...
Other Medicine News:Health News:Biomarker associated with poor outcome in aggressive childhood cancer 2Health News:Aurora BayCare is Wisconsin's First Nationally Accredited Breast Program 2Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 2Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 3Health News:Secretary of Health 'Walks the Walk' to Kick Off National Public Health Week 2Health News:N30 Pharma Forms Scientific Advisory Board 2
(Date:11/30/2009)...FIELD HILLS, Mich., Nov. 30 eHealt...e dedicated exclusively to products approved for F... (FSA/HSA) claims. The site is also the first to ...dications, saving shoppers up to 75 percent on eve...s cure two common healthcare headaches - high cost...
(Date:11/30/2009)...O, Nov. 30 Dr. Jocelyn Rapelyea, A...on at George Washington University Medical Center ...ns identified with Breast-Specific Gamma Imaging (...aging for needle biopsy as well, as for pre-operat...e Radiological Society of North America (RSNA). ,...
(Date:11/30/2009)...AGO, Nov. 30 MedPro Imaging, a pre...lutions, will showcase leading ultrasound solution...Siemens X300 Premium Edition during the company,s ...ca (RSNA) conference, being held in Chicago Novemb...maging markets ultrasound products and services in...
Breaking Medicine Technology:eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 1Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 2Novel handheld device detects anthrax with outstanding accuracy and reliability 12945 3Research shows that invisible hand guides evolution of cooperative turn taking 9182 1Research shows that invisible hand guides evolution of cooperative turn taking 9182 2Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 1Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 2Upcoming Beckman Coulter Investor Events Second Half of 2009 51160 3
...on Study in Patients with,Chronic Decompensated He...ardiology 56th Annual Scientific Session --, MOUNT...PRNewswire/ -- Scios Inc. announced today that an ...ide (NATRECOR(R)) showed a,neutral effect on the p...nal hospitalization at 12 weeks, and provides impo...
...ire/ -- A large patient,registry of "real world" u...tent reported favorable safety and efficacy outcom...vestigators at the of,Cardiology,s 56th Annual Sci... a prospective, single-arm study designed,to evalu...tion (PCI,or balloon angioplasty) with the CYPHER(...
Other Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 2Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 3Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 4
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: